GNPX
Genprex, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.04
+1.49%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-111.5%
Return on equity
-96.3%
Return on assets
-107.1%
Return on invested capital
0.00x
Asset turnover
-$15.6M
Cash from operations
$18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026